We are live on
!
Find out more
SCM
Shelton Capital Management Portfolio holdings
AUM
$4.57B
1-Year Est. Return
32.26%
This Fund
S&P 500
This Quarter
Est. Return
+10.16%
1 Year Est. Return
+32.26%
3 Year Est. Return
+110.31%
5 Year Est. Return
+153.06%
10 Year Est. Return
+630.09%
AUM
$661M
AUM Growth
+$63.6M
(+11%)
Cap. Flow
+$8.57M
Cap. Flow
% of AUM
1.3%
Top 10 Holdings %
Top 10 Hldgs %
16.59%
Holding
777
New
87
Increased
152
Reduced
160
Closed
27
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Axos Financial
AX
|
+$1.14M |
| 2 |
Intercontinental Exchange
ICE
|
+$1.1M |
| 3 |
Exelixis
EXEL
|
+$1.1M |
| 4 |
Tesla
TSLA
|
+$1.09M |
| 5 |
Intel
INTC
|
+$582K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$3.57M |
| 2 |
FLG
Flagstar Bank National Association
FLG
|
+$1.62M |
| 3 |
CELG
Celgene Corp
CELG
|
+$1.59M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$1.54M |
| 5 |
Ametek
AME
|
+$1.25M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.89% |
| 2 | Healthcare | 15% |
| 3 | Financials | 12.41% |
| 4 | Industrials | 10.23% |
| 5 | Energy | 8.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
FirstEnergy
FE
$27.1B
| $894K | 0.14% |
27,097
| – | – |
|
152
Ameren
AEE
$30B
| $893K | 0.14% |
24,708
| – | – |
|
153
Advance Auto Parts
AAP
$3.21B
| $882K | 0.13% |
7,972
-244
| -3% | -$24.2K |
|
|
ANSS
154
DELISTED
Ansys
ANSS
| $882K | 0.13% |
10,118
-335
| -3% | -$28.8K |
|
155
Cognizant
CTSH
$26B
| $874K | 0.13% |
17,304
-1,400
| -7% | -$63.8K |
|
156
Sempra
SRE
$56.1B
| $871K | 0.13% |
19,406
| – | – |
|
157
Adobe
ADBE
$102B
| $863K | 0.13% |
14,416
-123
| -0.8% | -$6.8K |
|
158
Phillips 66
PSX
$89.2B
| $857K | 0.13% |
11,113
+5,301
| +91% | +$354K |
|
159
Visa
V
$670B
| $856K | 0.13% |
15,380
| – | – |
|
|
ENDP
160
DELISTED
Endo International plc
ENDP
| $855K | 0.13% |
12,670
| – | – |
|
|
MRSH
161
Marsh
MRSH
$90.4B
| $852K | 0.13% |
17,625
| – | – |
|
162
PACCAR
PCAR
$68.8B
| $835K | 0.13% |
21,179
+2,556
| +14% | +$96.8K |
|
|
RKT
163
DELISTED
ROCK-TENN COMPANY CL-A
RKT
| $835K | 0.13% |
15,908
| – | – |
|
164
Everest Group
EG
$14B
| $830K | 0.13% |
5,322
-361
| -6% | -$55.1K |
|
165
Fortune Brands Innovations
FBIN
$5.77B
| $826K | 0.12% |
21,158
| – | – |
|
|
FLG
166
Flagstar Bank National Association
FLG
$5.92B
| $824K | 0.12% |
16,300
-33,334
| -67% | -$1.62M |
|
167
Southern Company
SO
$106B
| $819K | 0.12% |
19,912
-2,000
| -9% | -$82.5K |
|
|
SE
168
DELISTED
Spectra Energy Corp Wi
SE
| $814K | 0.12% |
22,856
| – | – |
|
|
FRX
169
DELISTED
FOREST LABORATORIES INC
FRX
| $813K | 0.12% |
13,541
-3,140
| -19% | -$158K |
|
170
Realty Income
O
$59B
| $806K | 0.12% |
22,268
| – | – |
|
171
Universal Health Services
UHS
$9.96B
| $806K | 0.12% |
9,915
| – | – |
|
|
TW
172
DELISTED
TOWERS WATSON & CO COM STK CL A (DE)
TW
| $800K | 0.12% |
6,267
| – | – |
|
173
CVS Health
CVS
$120B
| $799K | 0.12% |
11,165
+200
| +2% | +$12.8K |
|
174
United Rentals
URI
$70.4B
| $796K | 0.12% |
10,211
-213
| -2% | -$14.3K |
|
175
Mettler-Toledo International
MTD
$28.7B
| $795K | 0.12% |
3,277
-93
| -3% | -$22.7K |
|
Similar funds
SV
LNWTC
VCM
ACM
JRP
ASC
MA
GIBU
Shelton Capital Management's Q4 2013 Portfolio in Review
As of Q4 2013, Shelton Capital Management held 777 positions worth $661M, up 11% from $598M the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Shelton Capital Management's Q4 2013 filing shows 87 new, 152 increased, 160 reduced and 27 closed positions. Its largest new stake was Axos Financial: 63,596 shares worth $1.25M. The largest sale was BioMarin Pharmaceuticals, an estimated $3.57M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
- Shelton Capital Management's largest Q4 2013 buy was Axos Financial: 63,596 shares worth $1.25M.
- Shelton Capital Management added most to Tesla in Q4 2013, an estimated $1.09M increase.
- Shelton Capital Management's biggest Q4 2013 reduction was BioMarin Pharmaceuticals, cutting an estimated $3.57M.
- Shelton Capital Management fully exited Ametek in Q4 2013, selling an estimated $1.25M.
- Shelton Capital Management's ten largest holdings make up 17% of its $661M portfolio in Q4 2013.
- Shelton Capital Management opened 87 new positions and closed 27 in Q4 2013.
- Shelton Capital Management's portfolio value rose 11% quarter-over-quarter to $661M.
Based on Shelton Capital Management's 13F filing for Q4 2013, filed 22 Jan 2014.